Letko, Brosseau & Associates’s Amrize AMRZ Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRZ
Letko, Brosseau & Associates's AMRZ Position: Q3 2026 in Review
Letko, Brosseau & Associates sold out of Amrize (AMRZ) in Q3 2026, closing a stake of 4,941 shares — an estimated $262K sold.
Letko, Brosseau & Associates first reported a position in AMRZ in Q2 2025 and held it in 5 quarters. The position peaked at $13.6M in Q2 2025. 429 funds tracked by Wall St. Rank hold AMRZ as of Q3 2026.
- Letko, Brosseau & Associates reported no remaining Amrize position as of Q3 2026 after selling out during the quarter.
- Letko, Brosseau & Associates sold 4,941 Amrize shares in Q3 2026, an estimated $262K.
- Letko, Brosseau & Associates first reported a position in Amrize in Q2 2025 and held it in 5 quarters.
- Letko, Brosseau & Associates's Amrize position peaked at $13.6M in Q2 2025.
- 429 funds tracked by Wall St. Rank held Amrize as of Q3 2026.
Based on Letko, Brosseau & Associates's 13F filing for Q3 2026, filed 6 Nov 2026.